NIOX Group Plc (NIOX.L) Research

NIOX Group Plc is a worldwide company dedicated to innovating, developing, and distributing medical devices that measure fractional exhaled nitric oxide (FeNO). A key product is the NIOX VERO system, an easily portable and non-invasive diagnostic tool designed for immediate, on-site patient use. This system includes a compact device alongside a suite of disposable items like sensors, individual mouthpieces, and breathing handles, all essential for quantifying FeNO levels in patients. The company, which was founded in 2006 and is headquartered in Oxford, United Kingdom, was formerly known as Circassia Group Plc until its renaming to NIOX Group Plc in September 2022.

Market snapshot

Symbol
NIOX.L
Price
$57.60
Day change
+2.13%
Market cap
$242.4M
P/E ratio
34.08x
52-week range
53.84-77.6
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 3 months

Peer companies

  • Allergy Therapeutics plc (AGY.L)
  • Advanced Medical Solutions Group plc (AMS.L)
  • Animalcare Group plc (ANCR.L)
  • Avacta Group Plc (AVCT.L)
  • Beximco Pharmaceuticals Limited (BXP.L)
  • Diaceutics PLC (DXRX.L)
  • Faron Pharmaceuticals Oy (FARN.L)
  • Optima Health plc (OPT.L)

Open NIOX Group Plc (NIOX.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.